Dr. Nadia Yasmin Abidi, MD

Dr. Abidi practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Abidi's NPI, 1891180196, was assigned on April 2, 2015. Dr. Abidi holds Pennsylvania license MD470722.

Dr. Abidi's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Abidi's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Abidi is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Abidi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abidi practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Abidi's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Abidi is licensed in Pennsylvania.

CMS data shows 645 Medicare services from Dr. Abidi across 13 procedure codes in 2024, for 255 Medicare patients. Medicare paid $114,723 for them.

CMS counts 255 Medicare patients who saw Dr. Abidi in 2024. The largest group is 75 to 84, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abidi's median patient age at 76, with 36% women.

In 2024, Dr. Abidi wrote 87 Medicare Part D claims for 34 patients. 84% of them were for generic drugs. CMS names the drug for 39 of them, across 3 drugs with 11 or more claims each, at $96,562 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Abidi for performance year 2024, reported through an alternative payment model (APM). Dr. Abidi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of melanoma (skin cancer) excision by Dr. Abidi, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Abidi, published from 2014 to 2025. 2021 was the busiest year, with 2. The most frequent topics are Skin Neoplasms, Carcinoma, Squamous Cell and Diagnosis, Differential. Dr. Abidi has published most often in Dermatol Surg. Dr. Abidi's most frequent co-authors are David Raymond Carr, MD, Nicholas Joseph Golda, MD and Kathryn Therese Shahwan, MD.

CMS Open Payments shows 38 general payments to Dr. Abidi from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $684.